Possible neuroleptic malignant syndrome during paliperidone administration: a case report.
Mantas
Christos
C
Kalabokis
George
G
Goulia
Panagiota
P
Tourlakopoulos
Athanasios
A
Hyphantis
Thomas
T
Mavreas
Venetsanos
V
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007555:Isoxazoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000068882:Paliperidone Palmitate; D011569:Psychiatric Status Rating Scales; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D055815:Young Adult
D014150:Antipsychotic Agents; D007555:Isoxazoles; D011743:Pyrimidines; D000068882:Paliperidone Palmitate